英文字典中文字典51ZiDian.com

中文字典辞典英文字典 a b c d e f g h i j k l m n o p q r s t u v w x y z

smilax

n. 拔契属

拔契属

WordNet (r) 3.0 (2006) (WordNet)

Smilax
n 1: sometimes placed in Smilacaceae [synonym: {Smilax}, {genus
Smilax}]
2: fragile twining plant of South Africa with bright green
flattened stems and glossy foliage popular as a floral
decoration [synonym: {smilax}, {Asparagus asparagoides}]

The Collaborative International Dictionary of English v.0.48 (gcide)

Smilax \Smi"lax\, n. [L., bindweed, Gr. ???.] (Bot.)
(a) A genus of perennial climbing plants, usually with a
prickly woody stem; green brier, or cat brier. The
rootstocks of certain species are the source of the
medicine called sarsaparilla.
(b) A delicate trailing plant ({Myrsiphyllum asparagoides})
much used for decoration. It is a native of the Cape of
Good Hope.
[1913 Webster]

请选择你想看的字典辞典：

单词	字典	翻译
smilax	查看　smilax　在百度字典中的解释	百度英翻中〔查看〕
smilax	查看　smilax　在Google字典中的解释	Google英翻中〔查看〕
smilax	查看　smilax　在Yahoo字典中的解释	Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!

中文字典英文字典工具:

选择颜色:

<style type="text/css">#word104_1 br {display:none;}</style>
<form id="word104_1" method="post" action="http://tr.goldgoldprice.com/index.php" target="_blank">
<div style="width: 140px;border:1px solid #000;background-color:#ffffff;padding: 0px 0px;margin: 0px 0px;align:center;text-align:center;overflow:hidden;"><div id="xcolor1_1" style="font-size:12px;color:#183a00;line-height:16px;font-family: arial; font-weight:bold;background:#94abf0;padding: 3px 1px;text-align:center;"><a href="http://tr.goldgoldprice.com/" alt="英文字典中文字典" title="英文字典中文字典" id="word_name104_1" style="color:#000000;font-size:14px;text-decoration:none;line-height:16px;font-family: arial;" >英文字典中文字典</a></div><table width=100% style='align:center;text-align:left;font-size:12px;background-color:#ffffff;color:#333333;'>
<tr><td style="text-align:center;border:0"><input type=hidden name="word104_hi" value="1">输入中英文单字</td></tr><tr><td style="text-align:center;border:0"><input type="text" name="word104_input" value="" size=10 style="background-color:#ffffff;color:#000;text-decoration:none;font-family: arial;rial;border:1px solid #999;padding:1px!important;"></td></tr><tr style='line-height: 26px;'><td style="text-align:center;border:0"><input type=submit style="background-color:#ccc;color:#000;border:0 none;cursor:pointer;" value="查询字典"></td></tr></table></div>
</form>

英文字典中文字典相关资料:

Libtayo: Uses, Side Effects, Warnings - Drugs. com
Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
Cemiplimab-rwlc - NCI - National Cancer Institute
Cemiplimab-rwlc is a type of drug called an immune checkpoint inhibitor (a type of immunotherapy) It is a monoclonal antibody that binds to the protein PD-1 on the surface of immune cells called T cells It works by keeping cancer cells from suppressing the immune system This allows the immune system to attack and kill the cancer cells
Cemiplimab-rwlc (intravenous route) - Side effects uses
Cemiplimab-rwlc injection is also used to treat a type of skin cancer called basal cell carcinoma (BCC) that cannot be removed by surgery (locally advanced) or that has spread (metastatic) in patients who have received previous treatment with a hedgehog pathway inhibitor (HHI) or who cannot receive treatment with a HHI
Libtayo more favorable than Keytruda for first-line . . .
The FDA approved Libtayo in 2022 as a first-line treatment for advanced NSCLC, in combination with chemotherapy However, it has been unclear whether this new combination treatment could outperform Keytruda plus chemotherapy from a cost-effectiveness standpoint
Libtayo (Cemiplimab-rwlc Injection): Side Effects, Uses . . .
Libtayo (Cemiplimab-rwlc Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources
Libtayo (cemiplimab-rwlc) FDA Approval History - Drugs. com
Libtayo (cemiplimab-rwlc) is a programmed death receptor-1 (PD-1) blocking antibody for the treatment of cutaneous squamous cell carcinoma (CSCC), basal cell carcinoma (BCC), and non-small cell lung cancer (NSCLC) Cutaneous Squamous Cell Carcinoma (CSCC) Libtayo is indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC
label - accessdata. fda. gov
1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
Keytruda (pembrolizumab) vs Libtayo (cemiplimab) - Everyone. org
Libtayo (Cemiplimab) Efficacy in Lung Cancer Libtayo, or cemiplimab, is another immune checkpoint inhibitor targeting the PD-1 pathway, and it has shown promise in the treatment of NSCLC as well Similar to pembrolizumab, cemiplimab works by enhancing the body's immune response against cancer cells
Treatment in Advanced NSCLC | LIBTAYO® (cemiplimab-rwlc)
Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced non-small cell lung cancer (NSCLC) Review Important Safety Info Full Prescribing Information including Med Guide
Cemiplimab: Side Effects, Uses, Dosage, Interactions, Warnings
Cemiplimab is a cancer medicine that helps your immune system fight certain cancers What it treats Advanced or hard-to-treat: Some skin cancers (certain squamous cell and basal cell skin cancers) Some types of lung cancer (non–small cell lung cancer) Cemiplimab is available under the following different brand names: Libtayo, cemiplimab-rwlc

中文字典-英文字典 2005-2009